GlobeNewswire Inc.··NaDianthus Therapeutics Raises $625M in Upsized IPO Offering to Fund Pipeline Expansion
Dianthus Therapeutics prices $625M upsized offering at $81/share to fund drug development and commercial readiness. Closing expected March 12, 2026.
DNTHbiotechclinical-stage